Officer sold
Zimmer Biomet's SVP and CHRO sold $251K of Zimmer Biomet shares. Nobody planned it ahead of time.
Stake as of Dec 31, 2025 · Filed Feb 17, 2026
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Zimmer Biomet's SVP and CHRO sold $251K of Zimmer Biomet shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.